- Two publicly traded companies will offer shareholder distinct opportunities given unique ...
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- - First Randomized Controlled Trial to Show That Basal Plus ...
- - Human and in vivo Studies Indicate Lantus(R) Metabolites do not ...
- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific ...
- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Caesars Entertainment Corporation today announced the creation of a new unit to ...